Results 131 to 140 of about 21,434 (231)
Donepezil for severe Alzheimer's disease.
We feel that the paper by Bengt Winblad and colleagues1 on the use of donepezil for patients with severe Alzheimer's disease omits two essential points which should be considered when interpreting this study.
Fullwood, Nigel J. +3 more
core
ABSTRACT Background Evidence supporting the use of statins for primary prevention of cardiovascular disease (CVD) in individuals aged ≥ 80 years remains limited. This study aimed to evaluate the long‐term clinical benefits and safety of statins for primary prevention in patients aged 80 years and older.
Ophir Lavon, Wafaa Hamodi, Sameer Kassem
wiley +1 more source
Association of Combined Lifestyle Behaviors With Healthspan in Older Adults
In 11,287 older adults from the ASPirin in Reducing Events in the Elderly (ASPREE) cohort, healthy lifestyle behaviors were defined as Mediterranean diet, regular physical activity, moderate alcohol intake, and non‐smoking. Participants with three or more favorable behaviors had a 40% lower hazard of death, dementia, or persistent physical disability ...
Catherine Robb +13 more
wiley +1 more source
ABSTRACT Background Hip fractures are a significant public health concern, associated with substantial morbidity and mortality. Mortality is the most serious consequence of hip fractures, with a 1‐year rate ranging from 14% to 36%. Hospital harms are also more prevalent among older adults with hip fractures, further increasing their risk of mortality ...
Anum Ali +9 more
wiley +1 more source
Sensory Impairment and Risk of Elder Mistreatment in Community‐Dwelling Older Adults
Adjusted probabilities of elder mistreatment based on none, one, or multi‐sensory impairments (vision, hearing, and/or olfaction). Results suggest an association between multisensory loss and elder mistreatment risk. ABSTRACT Background Emotional and financial mistreatment among older adults is often under‐recognized among clinicians. Exploring whether
Mara W Rosenberg +6 more
wiley +1 more source
Donepezil: Pharmacoeconomic Implications of Therapy
_ Donepezil is a specific acetylcholinesterase inhibitor that can improve symptoms in patients with mild-to-moderate Alzheimer's disease; cognitive function is maintained above baseline levels for up to 1 year and normal decline of cognitive function is ...
Rachel H. Foster, Greg L. Plosker
core
ABSTRACT Securing a participant's voluntary, informed consent is widely acknowledged as a requirement of ethical research. Yet, challenges can arise, particularly when a researcher seeks to enroll older adults who may lack the capacity to consent to research participation due to cognitive impairment.
Emily A. Largent +2 more
wiley +1 more source
The effect of canagliflozin on hippocampal dendrite morphology in a model of Alzheimer's disease induced by intracerebroventricular injection of streptozotocin. [PDF]
Yazi S +9 more
europepmc +1 more source
Donepezil for dementia due to Alzheimer's disease
Donepezil for dementia due to Alzheimer's ...
Richard Harvey (13090974) +1 more
core
Entropy estimation in acetylcholinesterase-donepezil interaction through topological indices: a graph theoretical perspective. [PDF]
Gayathri KB, Roy S, Jyothish K.
europepmc +1 more source

